Biosimilars 2017 Year in Review

Since the passage of the Biologics Price Competition and Innovation Act (BPCIA), 2017 has been the most active year yet for drug manufacturers.

On February 7, 2018, the head of Fish's regulatory practice, Terry Mahn, testified in front of the U.S. Senate Special Committee on Aging and referenced this article as a resource for more information. Video of this testimony can be found here.

Click here to read the full article.